BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 29313579)

  • 1. Pancreatic Exocrine Insufficiency in Type 1 and 2 Diabetes: Therapeutic Implications.
    Talukdar R; Reddy DN
    J Assoc Physicians India; 2017 Sep; 65(9):64-70. PubMed ID: 29313579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [PANCREATIC EXOCRINE INSUFFICIENCY AND ITS CORRECTION IN CHILDREN WITH TYPE I DIABETES IN COMBINATION WITH CELIAC DISEASE].
    Bolshova EV; Lukashuk IV; Lukashuk VD
    Lik Sprava; 2015; (1-2):167-9. PubMed ID: 26118067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exocrine Pancreatic Insufficiency in Type 1 and Type 2 Diabetes.
    Radlinger B; Ramoser G; Kaser S
    Curr Diab Rep; 2020 Apr; 20(6):18. PubMed ID: 32239341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial.
    Ewald N; Bretzel RG; Fantus IG; Hollenhorst M; Kloer HU; Hardt PD;
    Diabetes Metab Res Rev; 2007 Jul; 23(5):386-91. PubMed ID: 17103488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic exocrine insufficiency in type 1 and type 2 diabetics of Indian origin.
    Shivaprasad C; Pulikkal AA; Kumar KM
    Pancreatology; 2015; 15(6):616-9. PubMed ID: 26549275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it?
    Domínguez-Muñoz JE
    Adv Med Sci; 2011; 56(1):1-5. PubMed ID: 21450558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which factors determine exocrine pancreatic dysfunction in diabetes mellitus?
    Altay M
    World J Gastroenterol; 2019 Jun; 25(22):2699-2705. PubMed ID: 31235993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic exocrine insufficiency: diagnostic evaluation and replacement therapy with pancreatic enzymes.
    Hammer HF
    Dig Dis; 2010; 28(2):339-43. PubMed ID: 20814209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of pancreatin minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis.
    Morawski JH; Prüfert A; van Engen A; Foerster D; Sander-Struckmeier S; Małecka-Panas E; Pezzilli R
    J Med Econ; 2012; 15 Suppl 1():15-25. PubMed ID: 23043594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of agenesis of the dorsal pancreas and a review of the literature.
    Mei W; Cao F; Li F
    BMC Gastroenterol; 2020 Apr; 20(1):94. PubMed ID: 32252649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Piehl S; Brinkmann R; Windeck T
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):635-6; author reply 636-7. PubMed ID: 20393298
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatic exocrine insufficiency in diabetes mellitus - prevalence and characteristics.
    Søfteland E; Poulsen JL; Starup-Linde J; Christensen TT; Olesen SS; Singh S; Vestergaard P; Drewes AM; Dimcevski G
    Eur J Intern Med; 2019 Oct; 68():18-22. PubMed ID: 31402275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension.
    Seiler CM; Izbicki J; Varga-Szabó L; Czakó L; Fiók J; Sperti C; Lerch MM; Pezzilli R; Vasileva G; Pap A; Varga M; Friess H
    Aliment Pharmacol Ther; 2013 Apr; 37(7):691-702. PubMed ID: 23383603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of panzytrat--modern physiological enzyme preparation in complex therapy of pancreatic exocrine secretory insufficiency in cholelithiasis].
    Petukhov VA; Mironov AV; Semenov ZhS; Ustinov FS
    Eksp Klin Gastroenterol; 2009; (1):72-80. PubMed ID: 19551960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to: properties of different pancreatin preparations used in pancreatic exocrine insufficiency, Löhr JM et al. Eur J Gastroenterol Hepatol 2009; 21(9):1024-1031.
    Lederer PC
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):635; author reply 636-7. PubMed ID: 20393299
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between the exocrine and endocrine pancreas after acute pancreatitis.
    Das SL; Kennedy JI; Murphy R; Phillips AR; Windsor JA; Petrov MS
    World J Gastroenterol; 2014 Dec; 20(45):17196-205. PubMed ID: 25493036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid resistant lipase as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs.
    Griffin SM; Alderson D; Farndon JR
    Gut; 1989 Jul; 30(7):1012-5. PubMed ID: 2759481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus.
    Whitcomb DC; Bodhani A; Beckmann K; Sander-Struckmeier S; Liu S; Fuldeore M; Pollack PF; Khurmi RP
    Pancreas; 2016; 45(5):679-86. PubMed ID: 26495784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of exocrine and endocrine pancreatic insufficiency.
    Lankisch PG; Creutzfeldt W
    Clin Gastroenterol; 1984 Sep; 13(3):985-99. PubMed ID: 6435918
    [No Abstract]   [Full Text] [Related]  

  • 20. An elemental diet fed, enteral or parenteral, does not support growth in young pigs with exocrine pancreatic insufficiency.
    Rengman S; Fedkiv O; Botermans J; Svendsen J; Weström B; Pierzynowski S
    Clin Nutr; 2009 Jun; 28(3):325-30. PubMed ID: 19297056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.